Javascript must be enabled to continue!
Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county
View through CrossRef
AbstractBackgroundCandidemia is a diverse condition and associated with a broad spectrum of clinical presentation. As mortality is high, timely diagnosis of candidemia and start of correct therapeutic treatment are essential.ObjectivesTo investigate characteristics and factors influencing outcomes for patients with candidemia in a Swedish setting.MethodAll positive blood cultures for any Candida species in Östergötland County from 2012 to 2016 were screened. Medical records of patients fulfilling all inclusion criteria and no exclusion criteria were retrospectively reviewed to obtain data on risk factors, diagnostic and therapeutic procedures and at what wards candidemia was diagnosed. Univariate logistic regression and multivariable regression analysis were used to obtain odds ratio to determine risk factors for 30‐day all‐cause mortality associated with candidemia. A p‐value <.05 was considered statistically significant.ResultsOf all analysed risk factors, increasing age, renal failure with haemodialysis, immunosuppressant treatment, and severity of the infection (i.e. if septic shock was present) were significantly associated with 30‐day mortality in univariate analysis (p < .05). Removal of a central venous catheter or an infectious diseases consultant was associated with a significantly lower odds ratio for death at 30 days (p < .05). With multivariable analysis, age, time to start of treatment and infectious disease consultant remained significant (p < .05).ConclusionIn conclusion, this study provides an update of the epidemiology and outcomes of candidemia in a Swedish setting, highlighting that patients with candidemia are present at various departments and indicates the importance of an infectious disease consultant when candidemia is present.
Title: Factors influencing outcomes in candidemia: A retrospective study of patients in a Swedish county
Description:
AbstractBackgroundCandidemia is a diverse condition and associated with a broad spectrum of clinical presentation.
As mortality is high, timely diagnosis of candidemia and start of correct therapeutic treatment are essential.
ObjectivesTo investigate characteristics and factors influencing outcomes for patients with candidemia in a Swedish setting.
MethodAll positive blood cultures for any Candida species in Östergötland County from 2012 to 2016 were screened.
Medical records of patients fulfilling all inclusion criteria and no exclusion criteria were retrospectively reviewed to obtain data on risk factors, diagnostic and therapeutic procedures and at what wards candidemia was diagnosed.
Univariate logistic regression and multivariable regression analysis were used to obtain odds ratio to determine risk factors for 30‐day all‐cause mortality associated with candidemia.
A p‐value <.
05 was considered statistically significant.
ResultsOf all analysed risk factors, increasing age, renal failure with haemodialysis, immunosuppressant treatment, and severity of the infection (i.
e.
if septic shock was present) were significantly associated with 30‐day mortality in univariate analysis (p < .
05).
Removal of a central venous catheter or an infectious diseases consultant was associated with a significantly lower odds ratio for death at 30 days (p < .
05).
With multivariable analysis, age, time to start of treatment and infectious disease consultant remained significant (p < .
05).
ConclusionIn conclusion, this study provides an update of the epidemiology and outcomes of candidemia in a Swedish setting, highlighting that patients with candidemia are present at various departments and indicates the importance of an infectious disease consultant when candidemia is present.
Related Results
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina
P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina
Abstract
Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM
It is known that the incidence and epidemiology of candidemia ...
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients
AbstractBackgroundCritically ill COVID‐19 patients have a high risk for the development of candidemia due to being exposed to both well‐defined classical risk factors and COVID‐19‐...
P-1727. Defining Uncomplicated Candidemia suitable for “shorter is better” Treatment
P-1727. Defining Uncomplicated Candidemia suitable for “shorter is better” Treatment
Abstract
Background
The success of candidemia treatment depends on patient baseline characteristics, as well as clinical ...
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
A retrospective study of 76 episodes of candidemia in 73 patients with underlying hematological malignancy, from 1988 until 1997, has been conducted to evaluate the clinical charac...
P150 Profile of Candidemia in a national level HAI Surveillance Network of India
P150 Profile of Candidemia in a national level HAI Surveillance Network of India
Abstract
Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM
Background...
Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients
Development and validation of COVID‐19 associated candidemia score (CAC‐Score) in ICU patients
AbstractBackgroundThe development of candidemia is a highly fatal condition in severe COVID‐19 infection.ObjectivesThis study aimed to develop a candidemia prediction score in COVI...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
P-2141. Candidemia after Solid Organ Transplantation
P-2141. Candidemia after Solid Organ Transplantation
Abstract
Background
Invasive fungal infections, most commonly due to Candida, are a dreaded complication after solid orga...

